Zitel-ZITL What's Happening Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Zitel-ZITL What's Happening

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Roof who wrote (12460)	10/31/1997 4:54:00 PM
From: CMason	Read Replies (1) of 18263

Couple of comments -- Abbott inks dozens of deals a year. $1.4 mil is pocket change to them, but it may represent their view of a cheap way to contain a potential competitor. Is Abbott doing all the regulatory work for the filing, in addition to the sales and manufacturing? If not, BTIM will need lots of additional staff to deal with FDA. Trust me, I've been there. Have you? Also, royalties don't mean anything if there aren't any sales. There's an open question on whether third party payers will reimburse and whether physicians will prescribe. Also, while I thank you for your suggestion that I do the research, I know what the stuff purports to do. The question is, will it get FDA approval, and will it sell anything? Finally, keep in mind that the stock is currently trading about 50% above what Montgomery set as their 12-18 month price target a couple of months ago. Even if you buy BTIM's entire story (which I admit I don't), that looks richly priced to me. Best of luck to you, my friend. CMason

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next